A protein called HIRA controls how fat cells work and helps your body manage weight and blood sugar, according to research reviewed by Gram. When scientists removed HIRA from fat cells in mice, the animals had worse blood sugar control and gained less weight on a high-fat diet. HIRA works by helping genes that make adiponectin—a hormone that keeps blood sugar healthy—get fully activated. This discovery, published in 2026, identifies a potential new target for treating obesity and diabetes, though human studies are still needed.
Scientists discovered that a protein called HIRA acts like a master switch for how our body stores fat and controls blood sugar. When researchers removed HIRA from fat cells in mice, the animals became less able to control their blood sugar and didn’t gain as much weight on a high-fat diet. This finding, published in 2026 in the Proceedings of the National Academy of Sciences, suggests that HIRA controls whether our fat cells make important chemicals that help our body work properly. Understanding this protein could lead to new treatments for obesity and diabetes.
Key Statistics
A 2026 study in the Proceedings of the National Academy of Sciences found that mice lacking the HIRA protein in fat cells showed impaired insulin sensitivity and reduced fat tissue expansion when fed a high-fat diet.
According to research reviewed by Gram, HIRA facilitates the production of adiponectin, a hormone critical for glucose homeostasis and metabolic health, by promoting RNA polymerase II pause release at adiponectin gene promoters.
The 2026 research demonstrated that HIRA binds to promoters and enhancers of lipid metabolism genes in fat cells, controlling the expression of multiple genes essential for proper fat cell function.
The Quick Take
- What they studied: How a protein called HIRA controls whether fat cells work properly and help our body manage weight and blood sugar
- Who participated: Laboratory mice genetically engineered to lack the HIRA protein in their fat cells, compared to normal mice
- Key finding: Mice without HIRA in their fat cells had worse blood sugar control and gained less weight when eating a high-fat diet, suggesting HIRA is important for normal fat cell function
- What it means for you: This research identifies a potential new target for treating obesity and type 2 diabetes, though human studies are needed before any treatments could be developed. The findings are promising but still in early laboratory stages.
The Research Details
Researchers used genetically modified mice to study the role of HIRA, a protein that helps organize DNA in fat cells. They created mice missing the HIRA protein specifically in fat tissue, then compared how these mice responded to a high-fat diet compared to normal mice. The scientists also used advanced techniques to map where HIRA attaches to DNA and studied how it affects the production of important fat-related genes.
To understand the exact mechanism, researchers used a special system called dTAG that allowed them to quickly remove HIRA from cells and immediately measure what changed in gene activity. They combined this with techniques that measure newly made RNA and map protein locations on DNA, giving them a detailed picture of how HIRA works at the molecular level.
This multi-layered approach allowed the team to not just observe that HIRA matters, but to understand the specific steps in the process by which it controls gene activity in fat cells.
Understanding how fat cells work at the molecular level is crucial because obesity and type 2 diabetes affect hundreds of millions of people worldwide. Most previous research focused on what happens after genes are turned on, but this study reveals an earlier step in the process—how proteins like HIRA actually get genes started. By identifying HIRA’s role, scientists have found a new potential point where they might intervene to improve fat cell function and metabolic health.
This research was published in the Proceedings of the National Academy of Sciences, one of the most prestigious scientific journals. The study used multiple complementary techniques to verify findings, which strengthens confidence in the results. However, this is laboratory research in mice, so results may not directly translate to humans. The specific mechanisms identified are novel and would need independent confirmation by other research groups.
What the Results Show
When researchers removed HIRA from fat cells in mice, several important changes occurred. First, the mice had worse insulin sensitivity, meaning their bodies couldn’t control blood sugar as effectively. Second, when fed a high-fat diet, these mice gained less weight and had less fat tissue expansion compared to normal mice, suggesting that HIRA is necessary for fat cells to grow and multiply normally.
The researchers discovered that HIRA controls the production of adiponectin, a hormone made by fat cells that helps the body maintain healthy blood sugar and reduce inflammation. Without HIRA, fat cells produced much less adiponectin. HIRA also controls genes involved in breaking down and processing fats, which are essential for normal fat cell metabolism.
At the molecular level, the team found that HIRA works by helping RNA polymerase II—the cellular machine that reads genes—move along DNA more efficiently. Think of it like HIRA removes a traffic jam that was slowing down the reading process. This allows genes to be fully activated and produce the proteins the cell needs.
The research revealed that HIRA’s main job is not to start genes turning on, but to help them continue once they’ve started. The team found that HIRA binds to the promoters and enhancers (the control regions) of important fat-metabolism genes. Interestingly, HIRA appears to work independently of a common mechanism involving a protein called H3.3, suggesting it uses a different pathway than previously expected.
Previous research established that histone chaperones (proteins that organize DNA) are important for gene regulation, but HIRA’s specific role in fat cell function and obesity was not well understood. This study fills that gap by showing that HIRA is not just a general gene regulator, but specifically critical for maintaining healthy fat cell function. The finding that HIRA works by facilitating RNA polymerase II pause release is a novel mechanism that adds to our understanding of how genes are controlled in specialized cell types.
This research was conducted entirely in laboratory mice, so results may not directly apply to humans. The study doesn’t explain why HIRA specifically affects these genes or whether other proteins can compensate for HIRA loss. Additionally, the research examined only one aspect of fat cell function—future studies would need to explore how HIRA affects other important fat cell processes. The study also doesn’t address whether HIRA levels vary in obese humans or whether modifying HIRA could be safely done as a treatment.
The Bottom Line
Based on this research, there are no direct recommendations for people at this time, as the work is still in early laboratory stages. However, the findings suggest that future drug development targeting HIRA or its functions could potentially help treat obesity and type 2 diabetes. People interested in managing weight and blood sugar should continue following established recommendations: maintain a balanced diet, exercise regularly, and consult healthcare providers about personalized approaches. This research may eventually lead to new treatment options, but that is likely years away.
This research is most relevant to people with obesity, type 2 diabetes, or metabolic syndrome who might eventually benefit from new treatments. It’s also important for researchers studying obesity, diabetes, and gene regulation. Healthcare providers treating metabolic diseases should be aware of this potential therapeutic target. The general public should understand this as promising basic research that may eventually lead to better treatments, but not as something that affects current health recommendations.
This is fundamental research that identifies a potential target. Typically, 5-10 years of additional research would be needed to develop and test treatments in humans. If successful, regulatory approval could take several more years. People should not expect any clinical applications from this specific finding for at least 5-10 years.
Frequently Asked Questions
What is HIRA and why does it matter for weight loss?
HIRA is a protein that controls whether fat cells make important chemicals like adiponectin, which helps your body manage blood sugar and weight. According to 2026 research, mice without HIRA had worse blood sugar control, suggesting this protein is crucial for healthy metabolism.
Can I increase HIRA levels to lose weight?
Not yet—this is early laboratory research in mice. Scientists haven’t developed ways to safely increase HIRA in humans, and we don’t know if that would help with weight loss. Current proven methods like diet and exercise remain the best approach.
How does HIRA help fat cells work better?
HIRA acts like a traffic controller for genes, helping the cellular machinery read fat-related genes more smoothly. This allows fat cells to produce adiponectin and other proteins needed for healthy metabolism and blood sugar control.
When will treatments targeting HIRA be available?
This is fundamental research published in 2026. Typically, 5-10 additional years of research would be needed before any human treatments could be tested. If successful, regulatory approval would take several more years, so realistic timeline is 10+ years.
Does this research apply to people or just mice?
This study was conducted in mice, so results don’t directly apply to humans yet. However, the molecular mechanisms discovered are likely relevant to human biology, making this a promising foundation for future human research and potential treatments.
Want to Apply This Research?
- Track fasting blood glucose levels weekly and record body weight daily. Note any changes in energy levels and hunger patterns. This baseline data would be valuable if future treatments targeting HIRA become available, allowing comparison of personal metabolic changes.
- While waiting for potential future treatments, use the app to monitor and improve diet quality and exercise consistency. Focus on reducing high-fat processed foods and increasing physical activity—behaviors that help maintain healthy fat cell function through current, proven methods.
- Establish a long-term tracking system for metabolic markers (weight, blood sugar if monitored by healthcare provider, energy levels) and lifestyle factors (diet quality, exercise minutes). This creates a personal health baseline and helps identify patterns that correlate with metabolic improvements, preparing users to evaluate any future HIRA-targeted treatments.
This article describes laboratory research in mice and does not represent medical advice or approved treatments for humans. HIRA-targeted therapies do not currently exist for human use. People with obesity, diabetes, or metabolic concerns should consult with healthcare providers about evidence-based treatment options. This research is promising but remains in early stages; significant additional research is needed before any clinical applications. Do not make health decisions based solely on this research.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.